CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process

Altvater B, Kailayangiri S, Spurny C, Flugge M, Meltzer J, Greune L, Urban K, Schwoppe C, Brand C, Schliemann C, Hintelmann H, Harrach S, Hartmann W, Abken H, Kuehle J, Schambach A, Gorlich D, Berdel WE, Rossig C. CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process. Cancer Gene Ther. 2023 Oct. 30:1355-1368. doi:10.1038/s41417-023-00642-x. PMID: 37391502